Dr. Kades is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1245 Wilshire Blvd
Ste 775
Los Angeles, CA 90017Phone+1 213-484-5397Fax+1 213-484-9584
Summary
- Wagdy Kades, MD is a Rheumatologist based in Los Angeles, CA with a notable understanding of back pain. He completed his residency in Internal Medicine and Fellowship in Rheumatology at the University of Southern California/LAC+USC Medical Center. His medical education began at the University of Alexandria Faculty of Medicine, graduating in 1988. Dr. Kades has contributed to various publications, with his works being cited frequently by other publications in his field. He has also engaged in clinical trials, notably "A Phase II Study of M2951 in SLE". His expertise has been recognized by the Centers for Medicare & Medicaid Services and the American College of Rheumatology, granting him the Meaningful Use Stage 1 Certification and designating him a Fellow (FACR), respectively.
Education & Training
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Fellowship, Rheumatology, 1999 - 2001
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1995 - 1998
- University of Alexandria Faculty of MedicineClass of 1988
Certifications & Licensure
- CA State Medical License 1996 - 2026
- NM State Medical License 1998 - 2002
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- A Phase II Study of M2951 in SLE Start of enrollment: 2017 Jan 04
Publications & Presentations
PubMed
- 52 citationsDifferences Between the Tolbutamide-Boosted and the Insulin-Modified Minimal Model ProtocolsMohammed F. Saad, Garry M. Steil, Wagdy W Kades, Maged F. Ayad, Wagih A Elsewafy
Diabetes. 1997-07-01 - 305 citationsA comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Athe...Mohammed F. Saad, R. L. Anderson, Ami Laws, Richard M. Watanabe, W. W. Kades
Diabetes. 1994-09-01 - 99 citationsAngiotensin II increases glucose utilization during acute hyperinsulinemia via a hemodynamic mechanism.Thomas A. Buchanan, Hemant Thawani, Wagdy Kades, John G Modrall, Fred A. Weaver
The Journal of Clinical Investigation. 1993-08-01
Professional Memberships
- Member
- Fellow
- Member
Other Languages
- Spanish, Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: